Navigation Links
Ovary Removal Lowers Odds of Cancer in High-Risk Women
Date:1/13/2009

Study confirms women with BRCA mutations are wise to take preventive action

TUESDAY, Jan. 13 (HealthDay News) -- Removing the ovaries of women with a high risk of breast and ovarian cancer due to mutations in BRCA1 or BRCA2 genes does substantially reduce their risk of getting both cancers, a new study confirms.

Researchers from the University of Pennsylvania School of Medicine and Memorial Sloan-Kettering Cancer Center did what's known as a meta-analysis, pooling the results of several studies and re-analyzing them. Led by Dr. Timothy Rebbeck, a professor of epidemiology at the university, the research team looked at 10 published studies. The report appears in the Jan. 13 issue of the Journal of the National Cancer Institute.

The risk reduction, he said, is substantial but perhaps not as high as earlier studies have suggested.

But not everyone agrees with that assessment. An expert who reviewed the study said the actual risk reduction may be higher than Rebbeck's team found because surgical techniques and preventive approaches have improved since some of the studies they analyzed were done.

Rebbeck said that "the earlier studies in this area were suggesting something like a 95 percent risk reduction, a near complete reduction [in ovarian cancer risk] that was very encouraging." But his team found somewhat less of a risk reduction with the procedure that involves removing the ovaries and fallopian tubes, called a prophylactic salpingo-oophorectomy. They found a 79 percent reduced risk of ovarian cancer and a 51 percent reduced risk of breast cancer.

"The breast cancer number has been pretty consistent throughout history," Rebbeck said.

Women who have inherited mutations in the BRCA1 or BRCA2 genes have elevated risks of both breast and ovarian cancer. The lifetime risk of breast cancer ranges from 56 percent to 84 percent, according to the researchers, whereas the risk for ovarian cancer ranges from 36 percent to 46 percent for BRCA1 mutation carriers and 10 percent to 27 percent for BRCA2 mutation carriers.

Women with these gene mutations usually are counseled to help them choose strategies to reduce the risk, which might include removing the ovaries or breasts, as well as screening and other prevention techniques.

But even removal of the ovaries cannot guarantee that a woman will never get ovarian cancer, Rebbeck said. Sometimes, for instance, ovarian cells get left behind in the surgery, he explained.

Dr. Jeffrey N. Weitzel, chief of the division of clinical cancer genetics at the City of Hope Comprehensive Cancer Center in Duarte, Calif., said pooling the results of 10 studies provided "enough [statistical] power to have a strong observation of a beneficial effect for BRCA1 and BRCA2 carriers."

By combining studies, "we get greater confidence there is a high likelihood this is a real effect," he said.

But in reality, a woman undergoing preventive removal of the ovaries today would probably have "closer to a 90 percent" reduction in ovarian cancer risk, Weitzel estimated. That's because, he said, the surgery that's done now is more thorough than it was in years past.

For women who are BRCA1 or BRCA2 carriers, preventive ovary removal is often recommended at age 35 or after completion of childbearing, Rebbeck said. Another way to reduce risk would be for a woman to go on oral contraceptives in her 20s, before childbearing, he said.

More information

To learn more about the risk factors for ovarian cancer, visit the American Cancer Society.



SOURCES: Timothy Rebbeck, Ph.D., professor, epidemiology, University of Pennsylvania School of Medicine, Philadelphia; Jeffrey N. Weitzel, M.D., chief, division of clinical cancer genetics, and professor, oncology and population science, City of Hope Comprehensive Cancer Center, Duarte, Calif.; Jan. 13, 2009, Journal of the National Cancer Institute, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. SurgiQuest Announces First Single Port Procedure for Uterus and Ovary Removal Using AirSeal(TM) Access System
2. Recurrent low-grade carcinoma of the ovary less responsive to chemo than more common ovarian cancers
3. Ovary Removal Protects Some High-Risk Women
4. Hair Removal Forum Unveils New Doctor Finder Interface
5. Laser Beam Beauty: 'The Complete Guide to Laser Hair Removal' DVD released by Aesthetic VideoSource
6. Study Evaluates Laser Therapies for Hair Removal
7. Mayo Clinic estimates new, tiny, super-sensitive probe could cut colon polyp removal in half
8. LegalView Reports Cancer Risk for St. Louis Residents After Unapproved Asbestos Removal During Demolition
9. Latest Laser Fat Removal Procedure Now Available
10. TRIA Personal Laser Hair Removal System Now Available at Aesthetic Physician Offices
11. Virtual biopsy can tell whether colon polyp is benign without removal, Mayo researchers say
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ovary Removal Lowers Odds of Cancer in High-Risk Women
(Date:2/24/2017)... ... 2017 , ... With millions of Americans and people worldwide ... all are aware of our options and are empowered with strength and information ... of its newest edition of "Vision and Hearing" in USA Today, that will ...
(Date:2/24/2017)... ... ... The narrative in “ Signal 8: An Australian Paramedic’s Story ” (published ... experiences. Schanssema describes the tragedies he saw, as well as his struggles with grief ... initially unsure of the career path he wanted to take, found fulfillment in a ...
(Date:2/24/2017)... , ... February 24, 2017 , ... The California ... conference convening academic faculty engaged in or interested in palliative care education and research. ... will be held in North County San Diego on Sept. 28 and 29, 2017, ...
(Date:2/24/2017)... , ... February 24, 2017 , ... The International Association ... annual “Imagine Me Beyond What You See” body image mannequin art competition. Selected from ... be showcased and the winner revealed at the 31st annual iaedp Symposium, March 22 ...
(Date:2/24/2017)... , ... February 24, 2017 , ... The Radiology ... excellence in radiology marketing programs at the annual Building Better Radiology Marketing Programs ... Fort Worth Hotel in Fort Worth, Texas. Nine awards are given out in five ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis ... the global Urinary Incontinence market. The research answers the following ... marketed for Urinary Incontinence and their clinical attributes? How are they ...
(Date:2/23/2017)... 23, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), a ... proprietary products for the urology market, will release financial ... December 31, 2016 before the market open on Thursday, ... host a conference call and webcast to discuss its ... 2017 at 11:00 a.m. Eastern Time (10:00 a.m. Central ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis and Strategies ... Oesophageal Cancer market. The research answers the following questions: ... for Oesophageal Cancer and their clinical attributes? How are they positioned ...
Breaking Medicine Technology: